Fresenius Kabi is a global healthcare company with broad capabilities in Pharma, Nutrition,
MedTech, and BioPharma and deep specialization in the essential products medical
professionals depend on to provide lifesaving and life-sustaining care to patients with critical
and chronic conditions. The vast majority of these are used by clinicians in acute care
hospitals, infusion centers, oncology clinics, and similar care sites — but a significant number
support specialized activities in facilities like R&D labs and blood and plasma centers. Worldwide, Fresenius Kabi operates in more than 70 locations in 50 countries. Its corporate
headquarters is in Bad Homburg, Germany. Its US headquarters is in Lake Zurich, Illinois. In the US, Fresenius Kabi offers leading portfolios in the following sub-categories:
𝐏𝐡𝐚𝐫𝐦𝐚: Injectable Medicines (Oncology, Anesthesia & Analgesia, Anti-Infectives,
Critical Care) and IV Solutions
𝐍𝐮𝐭𝐫𝐢𝐭𝐢𝐨𝐧: Parenteral Nutrition
𝐌𝐞𝐝𝐓𝐞𝐜𝐡: Infusion Technologies, Blood Technologies, Cell & Gene Technologies, and
Plasma Technologies
𝐁𝐢𝐨𝐏𝐡𝐚𝐫𝐦𝐚: Biosimilars (Oncology and Immunology)